Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sybren L Meijer

Showing results (61-70 of 123) with videos related to

Pageof 13
Sort By:
Human Pathology|May 16, 2021
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer ReportingAlfred K Lam, Michael J Bourke, Renyin Chen, et al.
Nature Immunology|January 22, 2013
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissuesJochem H Bernink, Charlotte P Peters, Marius Munneke, et al.
Gastrointestinal Endoscopy|December 2, 2014
Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studiesMarnix Jansen, Dirk W Schölvinck, Ryoji Kushima, et al.
Annals of Surgery|January 7, 2017
Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional CancerJoel Shapiro, Katharina Biermann, David van Klaveren, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Gastroenterology|November 8, 2016
Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's EsophagusPrashanth Vennalaganti, Vijay Kanakadandi, John R Goldblum, et al.
The American Journal of Gastroenterology|May 13, 2021
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade DysplasiaNicola F Frei, Amir M Khoshiwal, Kadere Konte, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 17, 2020
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesTom van den Ende, Héctor G van den Boorn, Nadine M Hoonhout, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Surgical Endoscopy|October 19, 2019
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective studyEliza R C Hagens, Hannah T Künzli, Anne-Sophie van Rijswijk, et al.
Pageof 13

Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Human Pathology|May 16, 2021
Dataset for the reporting of carcinoma of the esophagus in resection specimens: recommendations from the International Collaboration on Cancer ReportingAlfred K Lam, Michael J Bourke, Renyin Chen, et al.
Nature Immunology|January 22, 2013
Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissuesJochem H Bernink, Charlotte P Peters, Marius Munneke, et al.
Gastrointestinal Endoscopy|December 2, 2014
Is it justified to ablate flat-type esophageal squamous cancer? An analysis of endoscopic submucosal dissection specimens of lesions meeting the selection criteria of radiofrequency studiesMarnix Jansen, Dirk W Schölvinck, Ryoji Kushima, et al.
Annals of Surgery|January 7, 2017
Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional CancerJoel Shapiro, Katharina Biermann, David van Klaveren, et al.
Translational Oncology|August 16, 2024
Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker studyCharlotte I Stroes, Sybren L Meijer, Geert-Jan Creemers, et al.
Gastroenterology|November 8, 2016
Discordance Among Pathologists in the United States and Europe in Diagnosis of Low-Grade Dysplasia for Patients With Barrett's EsophagusPrashanth Vennalaganti, Vijay Kanakadandi, John R Goldblum, et al.
The American Journal of Gastroenterology|May 13, 2021
Tissue Systems Pathology Test Objectively Risk Stratifies Barrett's Esophagus Patients With Low-Grade DysplasiaNicola F Frei, Amir M Khoshiwal, Kadere Konte, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 17, 2020
Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor typesTom van den Ende, Héctor G van den Boorn, Nadine M Hoonhout, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Surgical Endoscopy|October 19, 2019
Distribution of lymph node metastases in esophageal adenocarcinoma after neoadjuvant chemoradiation therapy: a prospective studyEliza R C Hagens, Hannah T Künzli, Anne-Sophie van Rijswijk, et al.
Pageof 13